Background
==========

Patients with mechanical valves require anticoagulation therapy, usually delivered by oral administration of warfarin, a vitamin K antagonist. Failure to administer adequate therapy monitored by serial measurement of INR carries the risk of thrombus formation on the artificial valve whose dislodgment can cause catastrophic outcomes \[[@B1]-[@B3]\]. Routine INR measurement and adequate anticoagulation can be performed in hospitals, community clinics and even at home. Patients with mechanical heart valves are usually aware of the dangers of inadequate therapy. Those who are hospitalized are usually well monitored by daily blood tests and INR measurements, especially when they are known to be taking warfarin. There are many reasons for discontinuing warfarin therapy, including the inability to take oral medications due to an acute medical condition or a disturbance in the normal coagulation cascade (e.g., disseminated intravascular coagulation). Patients who can not take their regular warfarin therapy are put on unfractionated or low molecular weight heparin therapy. Warfarin should not, however, be stopped in a patient with a mechanical valve, and if there is no other option, replacement therapy should be instilled until it can be reintroduced.

Case presentation
=================

A 47-year-old male was transferred to the emergency room from a hospital in the Gaza strip. The hospital's medical summary described a patient who had an artificial mitral valve in place for the past 10 years. He had currently been hospitalized for abdominal pain and diarrhea and was transferred to our hospital for further investigation when he developed lower limb weakness. The patient was intubated upon arrival due to decreased consciousness and hypotension. Fluid and dopamine resuscitation was initiated. No pulse was palpated in the lower extremities which were pale and cold on physical examination. Blood tests were notable for renal failure and an INR of 1.0. Computerized tomographic (CT) angiography demonstrated an artificial mitral valve (Figure [1](#F1){ref-type="fig"}, right arrow) and a thrombus in the left atrium which was not attached to the mechanical valve (Figure [1](#F1){ref-type="fig"}, left arrow). A lower abdomen scan (Figure [2](#F2){ref-type="fig"}) showed a thrombus (arrow) completely obstructing the descending aorta, causing abrupt stopping of the progression of the intravenous contrast media (white). A bedside echocardiographic examination showed the thrombus in the left atrium (Figure [3](#F3){ref-type="fig"}, arrow, and Figure [4](#F4){ref-type="fig"}, arrow). Multiple spleen (Figure [5](#F5){ref-type="fig"}, right arrow), renal (Figure [5](#F5){ref-type="fig"}, lower arrow) and leg muscles infarcts (Figure [6](#F6){ref-type="fig"}, arrow) were also evident. The patient underwent urgent descending aorta thrombectomy which restored blood flow to the extremities. He was transferred to the intensive care unit where he received further fluid and amine resuscitation as well as hemodialysis. After few days of supporting therapy and anticoagulation the patient died of shock and multi organ failure caused by shower thromboembolism.
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![Axial CT scan showing infarcts in the spleen (right arrow) and the left kidney (left arrow).](1756-0500-6-4-5){#F5}

![Axial CT scan showing a large infarct in the right quadriceps muscle (arrow).](1756-0500-6-4-6){#F6}

Comment
=======

We estimate that this patient underwent a prolong hospitalization due to a non- related disease of the gastrointestinal system. During this hospitalization, his regular warfarin treatment was either not administered or was administered in dosages that were inappropriately low for his special condition, hence the low INR level upon arrival. This caused the formation of a large thrombus attached to the artificial valve. This thrombus eventually dislodged and caused obstruction of the abdominal aorta. In this special case the patient was deprived of oral anticoagulant treatment before admission to our hospital and we encountered an exceptionally unique presentation of thromboemboli shower. This emphasizes the absolute need to switch to parenteral anticoagulation as early as possible in patients with mechanical valve at the mitral position.

Conclusion
==========

Anticoagulation therapy in a patient with an artificial valve is obligatory, even in those who are hospitalized due to an unrelated disease. Regular and frequent INR monitoring in such patients is advised as well. There are a number of reasons for inadequate anticoagulation therapy in hospitalized patients, among them the inability to take oral medications, failure to absorbed medications and medical conditions that require stopping the therapy (e.g. bleeding). The patient described in this report was unfortunately not provided adequate monitoring or treatment before he arrived to our hospital, and it was clear to us that the measures that we took by the time he came under our care were too late.

We report a rare catastrophic complication of multiple shower thromboembolism from the left atrium caused by complete occlusion of the abdominal aorta and multi organ infarcts in the spleen, kidney and muscle, although not causing a stuck valve. To our best knowledge, this is the first report of multiple embolism distribution with no thrombus in the patient's artificial mitral valve.
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